Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Andrea Ciaranello MD MPH, M.D.

Co-Author

This page shows the publications co-authored by Andrea Ciaranello MD MPH and Kenneth Freedberg.
Connection Strength

6.865
  1. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age. AIDS. 2015 Jun 19; 29(10):1247-59.
    View in: PubMed
    Score: 0.603
  2. Validation and calibration of a computer simulation model of pediatric HIV infection. PLoS One. 2013; 8(12):e83389.
    View in: PubMed
    Score: 0.543
  3. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis. 2013 Feb; 56(3):430-46.
    View in: PubMed
    Score: 0.505
  4. What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis. PLoS Med. 2012 Jan; 9(1):e1001156.
    View in: PubMed
    Score: 0.475
  5. Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts. Clin Infect Dis. 2021 11 02; 73(9):e2908-e2917.
    View in: PubMed
    Score: 0.235
  6. Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2021 10 05; 73(7):e1927-e1935.
    View in: PubMed
    Score: 0.233
  7. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic. medRxiv. 2020 Oct 20.
    View in: PubMed
    Score: 0.218
  8. College campuses and COVID-19 mitigation: clinical and economic value. medRxiv. 2020 Sep 05.
    View in: PubMed
    Score: 0.216
  9. Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts. medRxiv. 2020 Jul 24.
    View in: PubMed
    Score: 0.215
  10. Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis. J Acquir Immune Defic Syndr. 2020 07 01; 84 Suppl 1:S12-S21.
    View in: PubMed
    Score: 0.214
  11. Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers. MDM Policy Pract. 2020 Jan-Jun; 5(1):2381468320932894.
    View in: PubMed
    Score: 0.213
  12. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Jul; 6(7):ofz276.
    View in: PubMed
    Score: 0.199
  13. Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161). JMIR Res Protoc. 2019 Apr 16; 8(4):e9898.
    View in: PubMed
    Score: 0.197
  14. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. Lancet HIV. 2019 03; 6(3):e182-e190.
    View in: PubMed
    Score: 0.194
  15. HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing? Open Forum Infect Dis. 2018 Aug; 5(8):ofy170.
    View in: PubMed
    Score: 0.188
  16. Optimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk. J Int AIDS Soc. 2018 04; 21(4):e25107.
    View in: PubMed
    Score: 0.183
  17. The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV. J Adolesc Health. 2018 01; 62(1):22-28.
    View in: PubMed
    Score: 0.180
  18. The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis. PLoS Med. 2017 Nov; 14(11):e1002446.
    View in: PubMed
    Score: 0.178
  19. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017 10 15; 65(8):1266-1271.
    View in: PubMed
    Score: 0.177
  20. Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency. J Infect Dis. 2016 Nov 01; 214(9):1319-1328.
    View in: PubMed
    Score: 0.163
  21. Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for Elimination. Open Forum Infect Dis. 2015 Apr; 2(2):ofv073.
    View in: PubMed
    Score: 0.150
  22. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis. PLoS One. 2015; 10(3):e0117751.
    View in: PubMed
    Score: 0.148
  23. Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival. AIDS. 2014 Jul; 28 Suppl 3:S287-99.
    View in: PubMed
    Score: 0.141
  24. Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysis. Pediatr Infect Dis J. 2014 Jun; 33(6):623-9.
    View in: PubMed
    Score: 0.140
  25. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PLoS One. 2011; 6(6):e20224.
    View in: PubMed
    Score: 0.114
  26. Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med. 2011 May 20; 9:59.
    View in: PubMed
    Score: 0.114
  27. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20; 25(4):479-92.
    View in: PubMed
    Score: 0.112
  28. Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. Clin Infect Dis. 2010 Jul 01; 51(1):85-92.
    View in: PubMed
    Score: 0.107
  29. Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents. HIV Clin Trials. 2009 Jan-Feb; 10(1):13-24.
    View in: PubMed
    Score: 0.096
  30. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS. 2008 Nov 12; 22(17):2359-69.
    View in: PubMed
    Score: 0.095
  31. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. medRxiv. 2020 Oct 11.
    View in: PubMed
    Score: 0.054
  32. Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa. PLoS One. 2019; 14(11):e0225104.
    View in: PubMed
    Score: 0.051
  33. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study. Ann Intern Med. 2019 05 07; 170(9):614-625.
    View in: PubMed
    Score: 0.049
  34. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. Ann Intern Med. 2016 09 06; 165(5):325-33.
    View in: PubMed
    Score: 0.040
  35. Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy. Pediatr Infect Dis J. 2013 Jun; 32(6):644-7.
    View in: PubMed
    Score: 0.033
  36. Evolution of resistance in paediatric patients with failure on antiretroviral therapy. J Int AIDS Soc. 2012; 15(6):18086.
    View in: PubMed
    Score: 0.031
  37. The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa. Clin Infect Dis. 2013 Feb; 56(4):587-97.
    View in: PubMed
    Score: 0.031
  38. Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. PLoS Med. 2010 Dec 21; 7(12):e1000382.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.